{"id":379874,"date":"2020-11-12T09:33:01","date_gmt":"2020-11-12T14:33:01","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379874"},"modified":"2020-11-12T09:33:01","modified_gmt":"2020-11-12T14:33:01","slug":"wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/","title":{"rendered":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety <\/b><\/p>\n<p class=\"bwalignc\"><i>Sentri7 delivers patient-specific, real-time Morphine Milligram Equivalent calculation to support opioid stewardship and proactive pain management at hospitals<\/i><\/p>\n<p>WALTHAM, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fhealth%3Futm_source%3Dpress%26utm_medium%3Dpress%26utm_campaign%3Dhlrp-nurse-readiness-pr&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Wolters+Kluwer%2C+Health&amp;index=1&amp;md5=733637292dac851144055d8977da26ab\">Wolters Kluwer, Health<\/a> has announced its Sentri7 clinical program for hospital opioid stewardship is now powered by artificial intelligence (AI) to optimize inpatient opioid use and increase patient safety. Pharmacists can decrease the risk of opioid-related adverse events, identify opportunities for use of multi-modal (non-opioid) therapies and support earlier discontinuation of opioids. <\/b><\/p>\n<p>\nPart of the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fsolutions%2Fsolesource%2Fsentri7%2Fsentri7-ai-plus&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Sentri7+AI%2B+solution&amp;index=2&amp;md5=356f0721a942247c025a36e43e99c2ee\">Sentri7 AI+ solution<\/a>, Opioid Stewardship leverages machine learning to continuously analyze complex data sets and automatically calculate a patient-specific, real-time morphine milligram equivalent (MME) for opioid administrations. Sentri7\u2019s evidence-based rules utilize MME and patient-specific data to empower pharmacists\u2019 24\/7 monitoring of opioid use.\n<\/p>\n<p>\n\u201cHospitals are under increasing pressure to address proper use of opioids and we\u2019re helping to empower clinical and quality leaders with the data they need to directly identify high-priority areas for improvement,\u201d said <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fexperts%2Fsteven-riddle&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Steven+Riddle&amp;index=3&amp;md5=3789a079d0e62b5a83a2c7fc71c85623\">Steven Riddle<\/a>, PharmD, BCPS, FASHP, Director of Clinical Development. \u201cWolters Kluwer is applying AI and deep domain expertise to solve critical opioid stewardship challenges for health systems.\u201d\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F27484682%2F&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Data+shows&amp;index=4&amp;md5=7a2bca2f8bbfb953b8237e73e3da9b2b\">Data shows<\/a> that the longer a patient takes an opioid and the higher the dose, the likelihood increases that they will continue to use (or abuse) that drug going forward. Hospitals are often where people have their first exposure to opioid agents and therefore are ideal targets for reductions in unnecessary exposure or prolonged use.\n<\/p>\n<p>\nIn addition to integration of MME values into Sentri7 clinical decision support rules, the Opioid Stewardship Analytics dashboard also incorporates key metrics for managing appropriate opioid use and patient safety issues. These reports provide clinicians, quality specialists, risk managers, and others with in-depth insights, including average MME per patient per day, use per opioid standardized by MME, and trends by prescriber, department and hospital.\n<\/p>\n<p>\nThe Sentri7 Opioid Stewardship initiative improves overall organizational compliance with the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jointcommission.org%2Fresources%2Fpatient-safety-topics%2Fpain-management-standards-for-accredited-organizations%2F&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Joint+Commission%26%238217%3Bs+Pain+Assessment+and+Management+Standards&amp;index=5&amp;md5=0bffc9dd419ae8cfe6adb2a464b2db58\">Joint Commission\u2019s Pain Assessment and Management Standards<\/a> by identifying and monitoring patients at high risk for adverse events, improving use of non-opioid treatments, supporting pain management policies and protocols, and, most notably, creating a performance improvement model focused on opioid use.\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fsolutions%2Fsolesource%2Fsentri7%2Fopioid-stewardship&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Learn+more+about+Wolters+Kluwer%27s+solutions+to+improve+hospitals%27+opioid+stewardship+programs&amp;index=6&amp;md5=9c25ca95fdd7f871287de9bbaa66b146\">Learn more about Wolters Kluwer&#8217;s solutions to improve hospitals&#8217; opioid stewardship programs<\/a>.\n<\/p>\n<p><b>About Wolters Kluwer <\/b><\/p>\n<p>\nWolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.\n<\/p>\n<p>\nWolters Kluwer reported 2019 annual revenues of \u20ac4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.\n<\/p>\n<p>\nWolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fhealth&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.wolterskluwer.com%2Fen%2Fhealth&amp;index=7&amp;md5=7bd1b95bf0f25923ebf692a63327ce24\">https:\/\/www.wolterskluwer.com\/en\/health<\/a> and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwolters-kluwer-health%2F&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=8&amp;md5=5dfbf9750ece92f3d32a8a8194554032\">LinkedIn<\/a> and Twitter <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fwkhealth&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=%40WKHealth&amp;index=9&amp;md5=0eaad04cc5640446f3cfb714d49a3bd6\">@WKHealth<\/a>.\n<\/p>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwolterskluwer.com%2F&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=www.wolterskluwer.com&amp;index=10&amp;md5=4ef199546a34a011dad4ce93665e9596\">www.wolterskluwer.com<\/a>, follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FWolters_Kluwer&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Twitter&amp;index=11&amp;md5=8922b294c4d89e61abcd52f74dadbba0\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fwolterskluwer&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=Facebook&amp;index=12&amp;md5=13ac18a143fb3f917501f18e891c88ab\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwolters-kluwer%2F&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=13&amp;md5=5914c826945e2e0e12075a9dbe5ac947\">LinkedIn<\/a>, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fuser%2FWoltersKluwerComms&amp;esheet=52325683&amp;newsitemid=20201112005283&amp;lan=en-US&amp;anchor=YouTube&amp;index=14&amp;md5=8fbe85f62839af3a4947db228942887b\">YouTube<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201112005283\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201112005283\/en\/<\/a><\/span><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/>Andr\u00e9 Rebelo<br \/>\n<br \/>Public Relations Manager<br \/>\n<br \/>Wolters Kluwer<br \/>\n<br \/>+1 781.392.2411<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:andre.rebelo@wolterskluwer.com\">andre.rebelo@wolterskluwer.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Hospitals Clinical Trials General Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety Sentri7 delivers patient-specific, real-time Morphine Milligram Equivalent calculation to support opioid stewardship and proactive pain management at hospitals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Wolters Kluwer, Health has announced its Sentri7 clinical program for hospital opioid stewardship is now powered by artificial intelligence (AI) to optimize inpatient opioid use and increase patient safety. Pharmacists can decrease the risk of opioid-related adverse events, identify opportunities for use of multi-modal (non-opioid) therapies and support earlier discontinuation of opioids. Part of the Sentri7 AI+ solution, Opioid Stewardship leverages machine learning to continuously analyze complex data sets and automatically calculate a patient-specific, real-time morphine milligram equivalent (MME) for opioid administrations. Sentri7\u2019s evidence-based rules utilize MME &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379874","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety Sentri7 delivers patient-specific, real-time Morphine Milligram Equivalent calculation to support opioid stewardship and proactive pain management at hospitals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Wolters Kluwer, Health has announced its Sentri7 clinical program for hospital opioid stewardship is now powered by artificial intelligence (AI) to optimize inpatient opioid use and increase patient safety. Pharmacists can decrease the risk of opioid-related adverse events, identify opportunities for use of multi-modal (non-opioid) therapies and support earlier discontinuation of opioids. Part of the Sentri7 AI+ solution, Opioid Stewardship leverages machine learning to continuously analyze complex data sets and automatically calculate a patient-specific, real-time morphine milligram equivalent (MME) for opioid administrations. Sentri7\u2019s evidence-based rules utilize MME &hellip; Continue reading &quot;Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T14:33:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety\",\"datePublished\":\"2020-11-12T14:33:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/\"},\"wordCount\":600,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/\",\"name\":\"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-12T14:33:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/","og_locale":"en_US","og_type":"article","og_title":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk","og_description":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety Sentri7 delivers patient-specific, real-time Morphine Milligram Equivalent calculation to support opioid stewardship and proactive pain management at hospitals WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Wolters Kluwer, Health has announced its Sentri7 clinical program for hospital opioid stewardship is now powered by artificial intelligence (AI) to optimize inpatient opioid use and increase patient safety. Pharmacists can decrease the risk of opioid-related adverse events, identify opportunities for use of multi-modal (non-opioid) therapies and support earlier discontinuation of opioids. Part of the Sentri7 AI+ solution, Opioid Stewardship leverages machine learning to continuously analyze complex data sets and automatically calculate a patient-specific, real-time morphine milligram equivalent (MME) for opioid administrations. Sentri7\u2019s evidence-based rules utilize MME &hellip; Continue reading \"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T14:33:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety","datePublished":"2020-11-12T14:33:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/"},"wordCount":600,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/","name":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-12T14:33:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201112005283r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-applies-ai-technology-to-improve-hospital-opioid-use-and-patient-safety\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Wolters Kluwer Applies AI Technology to Improve Hospital Opioid Use and Patient Safety"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379874"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379874\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}